摘要
目的：观察奥司他韦联合炎琥宁治疗小儿病毒性肺炎的临床疗效。方法：随机选取收治的病毒性肺炎患儿260例,采用随机数字法将患儿分为对照组和观察组各130例。对照组给予注射用炎琥宁,使用剂量5-10 mg/kg,加入5%葡萄糖注射液250 ml,1次/d,静脉滴注。观察组在对照组治疗方案基础上给予磷酸奥司他韦颗粒（可威）口服,使用剂量：体重〈15 kg患儿30 mg/次,体重15-23 kg患儿45 mg/次,体重24-40 kg患儿60 mg/次,2次/d,口服。结果：观察组患儿的痊愈率和有效率明显高于对照组,差异具有统计学意义（P〈0.05）。结论：奥司他韦联合炎琥宁对于小儿病毒性肺炎具有良好的临床疗效。
Objective To observe the clinical effect of oseltamivir combined with potassium sodium dehydroandro in the treatment of infantile viral pneumonia. Method 260 cases with infantile viral pneumonia were selected and divided into the observation group and the control group,each group of 130 cases,according to random number table method. Control group were given dose 5 - 10 mg / kg potassium sodium dehydroandro in 250 ml 5% glucose injection,1 times a day,intravenous injection. Observation group were given oseltamivir phosphate grains on the basis of the control group therapy. Dosage： children with weight 〈15 kg 30 mg / times,children with weight 〈15 - 23 kg 45 mg / times,children with weight〈 24 to 40 kg 60 mg / times,2 times / d,oral. Results The cure rate and effective of observation group was obviously higher than that of control group,the difference was statistically significant（ P〈0. 05）. Conclusion The oseltamivir combined with potassium sodium dehydroandro has a good clinical effect on the treatment of infantile viral pneumonia.
出处
《吉林医学》
CAS
2016年第2期288-289,共2页
Jilin Medical Journal
关键词
奥司他韦
炎琥宁
小儿病毒性肺炎
Oseltamivir
Potassium sodium dehydroandro
Infantile viral pneumonia
